NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $170,000 | -62.5% | 30,507 | -8.9% | 0.00% | 0.0% |
| Q4 2021 | $453,000 | -93.3% | 33,500 | -47.2% | 0.00% | -75.0% |
| Q1 2018 | $6,742,000 | +3986.1% | 63,422 | +330.3% | 0.00% | +300.0% |
| Q3 2015 | $165,000 | -30.7% | 14,739 | -22.4% | 0.00% | 0.0% |
| Q2 2015 | $238,000 | +73.7% | 19,002 | +66.8% | 0.00% | – |
| Q3 2014 | $137,000 | +9.6% | 11,390 | +3.1% | 0.00% | -100.0% |
| Q4 2013 | $125,000 | -47.5% | 11,043 | -50.4% | 0.00% | 0.0% |
| Q3 2013 | $238,000 | +28.6% | 22,262 | +38.5% | 0.00% | -50.0% |
| Q2 2013 | $185,000 | -68.3% | 16,074 | -69.7% | 0.00% | -66.7% |
| Q1 2013 | $583,000 | +30.7% | 53,051 | -11.8% | 0.01% | +20.0% |
| Q4 2012 | $446,000 | – | 60,168 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |